Purchase Order 75N91024P00470
Award Date 6/9/24
Potential Completion Date 6/8/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a for-profit limited liability company and subsidiary of Danaher Corporation. The $5,402.27 contract does not have a set-aside designation and is for the procurement of specialized scientific equipment and services, including microplate readers, high-content imaging systems, electrophysiology equipment, and cellular...
- This is a $10,217 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a service agreement with an ultimate completion date of August 8, 2025. Molecular Devices is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company often receives sole-source awards as the original...
- This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI) to Molecular Devices LLC, a division of Danaher Corporation, for $10,217.00. The contract provides onsite performance assurance, including 1 annual preventive maintenance visit, parts, labor, and travel for repairs, as well as technical support priority response for a specialized laboratory instrument with serial number 373703698. The period of performance is from August 22, 2024 to August 21, 2025. This...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services. The $57,545.00 contract is for a service agreement to provide laboratory equipment from Molecular Devices LLC, a division of Danaher Corporation. The contract does not have a set-aside designation and has an ultimate completion date of October 31, 2023. Molecular Devices LLC, as the...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The $3,777 contract is for "OTHER FUNCTIONS" and does not have a set-aside designation. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions, including microplate readers, high-content imaging systems, and...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $4,216 contract is for the provision of specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement...
- This is a $24,540.00 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the provision of specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. Molecular Devices LLC is a leading manufacturer of high-performance bioanalytical measurement solutions for pharmaceutical and...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a SERVICE AGREEMENT FOR SPECTRAMAX M3 MULTI-MODE MICROPLATE READER. The potential value of the contract is $14,122.00 and the completion date is June 24, 2025. Molecular Devices LLC is a major provider of high-performance bioanalytical measurement solutions for life sciences...
- This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Molecular Devices LLC, a for-profit limited liability company that manufactures bioanalytical measurement solutions. The $10,217.00 maintenance agreement contract does not have a set-aside designation and has a performance period ending on March 31, 2025. Molecular Devices has previously provided specialized laboratory...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Molecular Devices LLC. The contract has a ceiling value of $10,061.98 and a period of performance through April 9, 2012. The award is for the procurement of Molecular Devices' bioanalytical laboratory instruments, equipment, and related services. Molecular Devices LLC is a subsidiary of the Danaher Corporation, a global...